netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Formulary Chapter 5: Infections - Full Chapter
Chapter Links...
 Details...
05.03.01  Expand sub section  HIV infection
05.03.01  Expand sub section  Nucleoside reverse transcriptase inhibitors
05.03.01  Expand sub section  Protease inhibitors
05.03.01  Expand sub section  Other antiretrovirals
Enfuvirtide
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine
High Cost Drug excluded to tariff 
   
Raltegravir
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine
High Cost Therapy excluded to tariff 
   
Cobicistat
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine
NHS England

Pharmacoenhancer
High Cost Therapy excluded to tariff
For use in line with NHSE policy only

 
Link  MHRA advice: Cobicistat, ritonavir and coadministration with a steroid: risk of systemic corticosteroid adverse effects
Link  NHSE Commissioning Policy: Use of cobicistat as a booster in treatment of HIV positive adults and adolescents
   
Dolutegravir
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine

High Cost Therapy excluded to tariff
Supported in line with NHSE policy only. 

MHRA Safety alert: Do not prescribe to women seeking to become pregnant; exclude pregnancy before initiation and advise use of effective contraception

 
Link  Dolutegravir (Tivicay, Triumeq, Juluca): signal of increased risk of neural tube defects
Link  NHSE Clinical Commissioning Policy: Dolutegravir
   
Dolutegravir, Abacavir and Lamivudine (Triumeq)
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine

High Cost Therapy excluded to tariff. Supported in line with NHSE policy only.

MHRA Safety alert: Do not prescribe to women seeking to become pregnant; exclude pregnancy before initiation and advise use of effective contraception

 
Link  Dolutegravir (Tivicay, Triumeq, Juluca): signal of increased risk of neural tube defects
Link  NHSE Clinical Commissioning Policy
   
Maraviroc
View adult BNF View SPC online
Restricted Drug Restricted
Red
High Cost Medicine
High Cost Therapy excluded to tariff
For use in treatment experienced adult patients infected with only CCR5-tropic HIV-1 virus. 
   
 ....
 Non Formulary Items
Dolutegravir, Rilpivirine  (Juluca®)

View adult BNF View SPC online Track Changes
Non Formulary
Black

Not yet reviewed

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry   

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).  

Amber SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.   

Amber Simple

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.  

Green Conditional

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.   

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.   

netFormulary